decrease Baht 8.97 Million or 3.26%. - Cost of the sales and services from Q2/2018 was 89.50% increased to 91.75% on Q2/2019 or increased 2.25% from sales due to recorded the effect of the change severance
fallen by THB 34.73 million, which has led 2nd quarter company’s net profit to fall to THB 0.69 million, a decrease of THB 16.05 million (96.2%). The main factors causing a sharp fall in underwriting
spectrum acquisition, but -1.8%QoQ from lower network OPEX. Regulatory fee was Bt1,409mn, relatively flat YoY, but - 3.4%QoQ along with the decrease in core service revenue. The fee was maintained at 4.3
% decrease. The promising growth of non-SW revenue was from IPD (49% growth) followed by OPD (14% growth) yoy. Both number of patients and revenue per head of 4Q19 increased. The higher revenue per head
margin in 2017 was 30%, which is considered high compared to other competitors, although it is lower than the previous year. The decrease was due to the impact of a change in foreign currency exchange
inventory showed Baht 483 million as of 30 September 2019, a decrease of Baht 63 million or 11.50% from last year-end resulting from lower unit cost of inventory. Liabilities : As of 30 September 2019, GC
%. And the sales value of Specialty Chemicals business unit was increased by 107.04%. The 9.58% decrease in total sales revenue was mainly due to the decline in sales value of Commodity Polymer business
, decreased by 1.48o/o when compared to the same period in the previous year, which had a total revenue of 40.42 million Baht. This decrease was attributed to lower domestic sales and lower revenue recognition
73 million in 3Q19 while reported net loss of Baht 60 million in 3Q2018. The closure of Dusit Thani Hotel Bangkok at the beginning of the year was the main reason to the decrease in business’s result